814-815 / 1578
SABR – Toxicity in peripheral tumors
•
No decreases in quality of life: Systematic review of 9 prospective studies
1
•
Chest wall pain of CTCAE Grades II or higher in 1-19 % of patients;
fractures in between 2-39 %
2
•
SABR-related
mortality
of approximately
16%
in patients with preexisting
interstitial lung disease: Systematic review
3
1
Chen H, Clin Lung Cancer 2016;
2
Shaik T, Cancer Treat Rev 2014;
3
Chen H, Int J Rad Onc Biol Phys 2017